Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage
- 19 August 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (33), 11851-11856
- https://doi.org/10.1073/pnas.0805462105
Abstract
Mutation of the RB-1 and p53 tumor suppressors is associated with the development of human osteosarcoma. With the goal of generating a mouse model of this disease, we used conditional and transgenic mouse strains to inactivate Rb and/or p53 specifically in osteoblast precursors. The resulting Rb;p53 double mutant (DKO) animals are viable but develop early onset osteosarcomas with complete penetrance. These tumors display many of the characteristics of human osteosarcomas, including being highly metastatic. We established cell lines from the DKO osteosarcomas to further investigate their properties. These immortalized cell lines are highly proliferative and they retain their tumorigenic potential, as judged by their ability to form metastatic tumors in immunocompromised mice. Moreover, they can be induced to differentiate and, depending on the inductive signal, will adopt either the osteogenic or adipogenic fate. Consistent with this multipotency, a significant portion of these tumor cells express Sca-1, a marker that is typically associated with stem cells/uncommitted progenitors. By assaying sorted cells in transplant assays, we demonstrate that the tumorigenicity of the osteosarcoma cell lines correlates with the presence of the Sca-1 marker. Finally, we show that loss of Rb and p53 in Sca-1-positive mesenchymal stem/progenitor cells is sufficient to yield transformed cells that can initiate osteosarcoma formation in vivo.Keywords
This publication has 26 references indexed in Scilit:
- Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130Genes & Development, 2004
- Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entryNature, 2003
- Comparison ofp53 mutations in patients with localized osteosarcoma and metastatic osteosarcomaCancer, 2001
- The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic DifferentiationMolecular Cell, 2001
- Developmental defects and tumor predisposition in Rb mutant miceOncogene, 1999
- Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.Journal of Clinical Oncology, 1996
- Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic typeCancer, 1995
- Cooperative tumorigenic effects of germline mutations in Rb and p53Nature Genetics, 1994
- p53 and the Li-Fraumeni syndromeCancer Genetics and Cytogenetics, 1993
- Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.1988